BioSpace News Archive

Job Trends

Top Biopharma M&As in 2019

The year was marked by mergers and acquisitions both big and small. Although not comprehensive, here’s a look at some of the top deals for 2019.

December 30, 2019
·
9 min read
·
Mark Terry
Business

Sumitomo Dainippon and Roivant Close Deal to Form Sumitovant Biopharma

Sumitovant will run as a wholly owned subsidiary of Sumitomo Dainippon Pharma.

December 30, 2019
·
3 min read
·
Mark Terry
Career Advice

What’s Wrong With Your Job Hunt? Diagnosing an Unproductive Search

If you’ve been on the hunt for a job for longer than you’d like, you might need to change your method. Here are tips, tricks and common mistakes to avoid to make your job search more productive.

December 30, 2019
·
4 min read
·
Katharine Hansen, PhD
Biotech Stocks Look Strong Heading into 2020, Analyst Says

Even as multiple plans have been put forth by federal lawmakers to address drug pricing, including the legislation passed by the House earlier this month, some analysts do not think biotech stocks will be as volatile heading into the 2020 election.

December 30, 2019
·
2 min read
·
Alex Keown
Seeking Out Professional Development for Biopharma Professionals

What options do biopharma professionals have when they want to spread their wings, advance in their careers and build skills to change their career direction?

December 30, 2019
·
5 min read
·
Katharine Hansen, PhD
Business

Four Major Biopharma Scandals in 2019

There were a number of scandals in the biopharma industry that caught our attention in 2019. Here’s a look at four of them.

December 30, 2019
·
5 min read
·
Alex Keown
Policy

Chinese CRISPR Researcher Receives 3-Year Prison Sentence and $430,000 Fine

The Shenzhen Nanshan District People’s Court sentenced He today to three years in prison and a fine of 3 million yuan ($430,000 U.S.). Two other medical researchers, Zhang Renli and Qin Jinzhou, worked with He and were also sentenced.

December 30, 2019
·
3 min read
·
Mark Terry
Biotech Beach

Experimental Gene Therapy Shows Promise for Preventing and Treating Lou Gehrig’s Disease in Mice

Researchers at the University of California San Diego School of Medicine published research describing a new way to deliver a gene-silencing vector to mice with ALS.

December 30, 2019
·
2 min read
·
Mark Terry
FDA

FDA Approves AstraZeneca and Merck’s Lynparza for Pancreatic Cancer

AstraZeneca and Merck are closing out 2019 on a high note with another approval for its PARP inhibitor Lynparza.

December 30, 2019
·
3 min read
·
Alex Keown
Policy

High Cost of Insulin Remains a Concern as Lawmakers Head into 2020 Election

Over the course of 2019, there have been numerous reports that show the increasing price of the medication is keeping it out of reach of patients. Some lawmakers are placing the blame squarely on the shoulders of drugmakers.

December 30, 2019
·
3 min read
·
Alex Keown